Weight loss injections in your area: what the evidence actually shows

What the trial data tells us about how these injections work

Tirzepatide and semaglutide belong to the same broad family of medicines but act slightly differently. Semaglutide activates one gut-hormone receptor (GLP-1) to slow how quickly food leaves the stomach and to signal fullness. Tirzepatide activates two: GLP-1 and GIP. That dual mechanism is why it is sometimes described as a more targeted approach, and it is the only dual-agonist weight management medicine currently licensed in the UK.

In SURMOUNT-1, which randomised 2,539 adults with obesity but without type 2 diabetes, participants taking tirzepatide 15mg lost an average of around 20–21% of their body weight over 72 weeks, compared with roughly 3% on placebo. The STEP 1 trial, published in the same journal, showed semaglutide 2.4mg producing an average loss of around 15% over 68 weeks. These are population averages from large randomised trials, individual results vary, and why results differ between people is a question our prescribers hear regularly.

Both medicines are Black Triangle (▼) products, meaning the MHRA collects additional post-market safety data. That is a standard designation for newer medicines, not a reason for concern, but it does underline why ongoing clinical oversight matters throughout treatment.

What living with a weekly injection actually looks like

A question people often have is whether self-injecting at home is manageable. For most people, it becomes unremarkable within a few weeks. Each pen is pre-filled; the needle is small; the injection takes seconds. Typical sites are the abdomen, thigh, or upper arm, rotated each week to avoid skin irritation.

Storage fits naturally into an ordinary routine. Unused pens sit in the fridge (many people keep them in the door) and the patient information leaflet specifies exactly how long a pen remains usable once it has been out at room temperature. That detail is worth reading carefully before any travel or change in routine. If you want to be prepared from day one, our guide to using your injection correctly covers technique and what to have ready.

The most commonly reported side effects are gastrointestinal: nausea, loose stools, constipation, indigestion, and occasional vomiting. These tend to be most noticeable after starting or after a dose increase, and they generally settle. Severe, persistent stomach pain that radiates to the back is different, that needs prompt medical attention, as the MHRA's guidance on GLP-1 medicines notes acute pancreatitis as a known, if infrequent, risk. The NHS tirzepatide page lists side effects clearly and is a practical first reference.

Does location affect who can get weight loss injections on the NHS?

In practice, yes, though the restriction is about NHS commissioning tiers, not postcodes in a simple sense. Tirzepatide became available through the NHS from June 2025 for adults with a BMI of 40 or above and four or more specific weight-related conditions. Semaglutide (Wegovy) has been available through specialist NHS weight management services since 2023 but typically involves long waiting lists. Our page on getting weight loss injections through your GP explains the NHS commissioning picture in more detail.

For people who do not meet NHS criteria yet, or who cannot wait, a regulated private pharmacy is the other legal route. The licensed eligibility criteria for private prescription are set out in the medicines' licensed indications: adults with a BMI of 30 or above, or 27 or above with at least one weight-related condition such as high blood pressure, high cholesterol, type 2 diabetes, or obstructive sleep apnoea. Lower BMI thresholds apply for some ethnic backgrounds under UK guidance. A prescriber assesses the full picture at consultation, BMI alone is not a green light.

For a broader comparison of the injections currently licensed in the UK, the overview of the three main options is a useful starting point. And if you are curious about what a private route involves in terms of cost, the treatment overview page covers what is included.

How to access weight loss injections safely, wherever you are

Geography is not the barrier it once was. A regulated online pharmacy can legally prescribe and dispense these medicines to adults across the UK, provided a prescriber has assessed suitability, and our guide to weight loss injections explains how the process works from first consultation through to ongoing treatment. The safeguard is verifying that the pharmacy is GPhC-registered, every legitimate online pharmacy appears on the GPhC register, which is publicly searchable.

The MHRA has issued repeated warnings about counterfeit weight loss pens sold online and through social media. Fake pens have been found to contain insulin rather than the labelled medicine, which is dangerous. Sellers offering these injections without a prior clinical assessment, at prices far below the market range, or through informal channels, are a serious red flag. Report any suspect seller via the MHRA's Yellow Card scheme.

At nume, every consultation is read and decided by a GPhC-registered Independent Prescriber, a real clinician, not an automated system. Identity and weight are verified before any medicine is dispensed. Treatment arrives in plain, unbranded packaging the next working day by tracked DPD delivery. If you want to find out whether you are clinically suitable, you can check your eligibility with a free consultation today, or head straight to our page for buying weight loss injections to see your options and get started.